INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced the publication of new data from the Phase IIIb OTEMTO ® 1&2 trials (NCT01964352 ...
A post-hoc analysis from OTEMTO ® 1&2 indicates that Spiolto ® Respimat ® provides significant quality of life improvements over Spiriva ® Respimat ® (tiotropium) or placebo, right from the initial ...
Boehringer Ingelheim today announced new data from two trials presented at the European Respiratory Society (ERS) International Congress 2015. A posthoc analysis from OTEMTO® 1&2 indicates that ...
The FINANCIAL — Boehringer Ingelheim on July 2 announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in first European countries ...
GlaxoSmithKline and Innoviva say their combination lung therapy Anoro Ellipta has come out on top in a trial pitting its effectiveness in improving lung function against that of Boehringer Ingelheim’s ...
Boehringer Ingelheim today announced new data from two trials presented at the European Respiratory Society (ERS) International Congress 2015. A post-hoc analysis from OTEMTO ® 1&2 indicates that ...
Boehringer Ingelheim today announced regulatory authority approvals for Spiolto ® Respimat ® (tiotropium/olodaterol) in first European countries. Spiolto ...
Data presented at European Respiratory Society International Congress 20181 In addition, the general condition of the patients was evaluated by the treating physician using the 8-point Physician’s ...
Further data from the 1,600 patient OTEMTO® trials show Spiolto® Respimat® provides: clinically meaningful improvements in breathlessness compared to placebo (measured by a 1.62 point improvement in ...
Boehringer Ingelheim today announced the publication of new data from the Phase IIIb OTEMTO ® 1&2 trials (NCT01964352/NCT02006732), which show Spiolto ® Respimat ...
OTEMTO trials show Spiolto Respimat provides clinically meaningful >4 point reduction in SGRQ score compared to placebo i The results underline the benefit Spiolto Respimat can bring to the daily life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results